MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Drug-induced parkinsonism(DIP)"

  • MDS Virtual Congress 2020

    Neuroprotective effects of allicin microemulsion against intrastriatal rotenone and manganese induced Parkinsonism in rats

    S. Singh (Moga, India)

    Objective: Allicin is flavonoid that possess neuroprotective potential but main impediment is its low bioavailability which was improved with microemulsion. The present study was framed…
  • MDS Virtual Congress 2020

    Predictors of Underlying Neurodegeneration in Drug-Induced Parkinsonism

    W. Aamodt, J. Dubroff, G. Cheng, B. Taylor, S. Wood, J. Duda, J. Morley (Philadelphia, PA, USA)

    Objective: To examine a cohort of Veterans with drug-induced parkinsonism (DIP) using [123I]Ioflupane single photon emission computed tomography (DAT-SPECT) to identify those with nigrostriatal degeneration…
  • MDS Virtual Congress 2020

    Inertial-sensor based full-body kinematics reveals an unstable gait with increased variability in patients with evidence of dopaminergic denervation with 123I-FP-CIT SPECT

    M. Mendonça, J. Silva, F. Oliveira, A. Oliveira-Maia, J. Ferreira, D. Costa, R. Costa, R. Matias (Lisboa, Portugal)

    Objective: Distinguish patients with and without dopaminergic denervation (as assessed by 123I-FP-CIT-SPECT – DaTscan) with Inertial-sensor full body kinematics (FBK) assessment. Background: The differential diagnosis…
  • MDS Virtual Congress 2020

    Comparing the effects of rosemary and selegiline on behavioral symptoms of Parkinson’s animal model in mice

    M. Modaresi (Isfahan, Islamic Republic of Iran)

    Objective: Parkinson is from common disorders of central nervous system and the second disease in neurodegenerative diseases which occurs in 1% of people over the…
  • MDS Virtual Congress 2020

    Anti-parkinson effect of natural L-DOPA containing drug Mucuna pruriens against the rotenone induced rat model of Parkinson’s disease

    V. Kumar, F. Anwar (Allahabad, India)

    Objective: The nanoherbaceutical formulation comprising natural L-DOPA from Mucuna pruriens against rotenone caused Parkinson's disease in rats to be prepared and evaluated. Background: Parkinson's disease…
  • MDS Virtual Congress 2020

    Substantia nigra echogenicity as a predictor of drug withdrawal response in suspected drug-induced parkinsonism: a five year follow-up study

    B. Baena Álvarez, R. Sainz Amo, F. Rodríguez Jorge, J. Gómez Corral, F.J Buisán Catevilla, N. García Barragán, I. Corral Corral, A. Felipe Mimbrera, M.C Matute Lozano, J. Masjuán Vallejo, J.C Martínez Castillo, J.L López-Sendón, A. Alonso Cánovas (Madrid, Spain)

    Objective: To asses the role of transcranial sonography in suspected drug-induced parkinsonism. Background: Differential diagnosis between drug-induced parkinsonism (DIP) and Parkinson’s disease (PD) is challenging,…
  • MDS Virtual Congress 2020

    Transcranial brain sonography can distinguish drug induced parkinsonism from idiopathic Parkinson’s disease in Korean?

    M. Park, H. Park (Daegu, Republic of Korea)

    Objective: ​​​​​​This was a prospective study to evaluate distinction of trans cranial sonograph(TCS) findings of the SN(sustantia nigra) in patients who were recent-onset of durg…
  • MDS Virtual Congress 2020

    Abrogation of neuroinflammation and behavioural deficit by Chlorogenic acid and Tinosporia cordiofolia in MPTP-Induced Parkinsonian mice model via suppressing NF-κB pathway

    D. Singh, M. Singh (Allahabad, India)

    Objective: The current study was designed with the aim to investigate the anti-neuroinflammatory activity of chlorogenic acid (CGA) and ethanolic extract of Tinospora cordifolia (TPE)…
  • MDS Virtual Congress 2020

    Asymmetrical resting legs tremor induced by levosulpiride

    W. Yoon (Seoul, Republic of Korea)

    Objective: Our aim is to report unusual case of woman who presented asymmetrical resting tremor of both legs induced by levosulpiride. Background: Resting tremor of…
  • MDS Virtual Congress 2020

    Thiazolidinedione use is associated with reduced risk of Parkinson’s disease in patients with diabetes

    S. Hussain, A. Singh, H. Baxi, B. Taylor, J. Burgess, B. Antony (Delhi, India)

    Objective: This meta-analysis is aimed to explore the association between thiazolidinedione (TZD) use and Parkinson’s disease (PD) risk. Background: Recent epidemiological studies found protective effects of TZD class of drugs in…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley